Phase II prospective trial of primary lung tumor stereotactic body radiation therapy (SBRT) followed by concurrent mediastinal chemoradiation and adjuvant immunotherapy for locally-advanced non-small cell lung cancer (NSCLC): Planned toxicity analysis Meeting Abstract
| Authors: | Heinzerling, J. H.; Mileham, K. F.; Robinson, M. M.; Symanowski, J. T.; Induru, R. R.; Prabhu, R. S.; Gant, D. A.; Pal, S. E.; Haggstrom, D. E.; Kim, E. S.; Burri, S.; Simone, C. B. |
| Abstract Title: | Phase II prospective trial of primary lung tumor stereotactic body radiation therapy (SBRT) followed by concurrent mediastinal chemoradiation and adjuvant immunotherapy for locally-advanced non-small cell lung cancer (NSCLC): Planned toxicity analysis |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368307536 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.e21047 |
| Notes: | Meeting Abstract: e21047 -- Source: Wos |
